联合用药-话题@MedSci

#联合用药#

68篇内容 | 3400人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1514299, encodeId=bd771514299ba, content=<a href='/topic/show?id=9d7c80e14b3' target=_blank style='color:#2F92EE;'>#联合用药#</a>, objectTitle=抗肿瘤药联合用药的早期临床方案设计思路及主要问题｜2019DDI, objectType=article, longId=182186, objectId=4dcc182186f2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4dcc182186f2, replyNumber=0, likeNumber=76, createdTime=2019-11-01, rootId=0, userName=ms4964546379600229, userId=36f510649899, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4dcc182186f2, moduleTitle=抗肿瘤药联合用药的早期临床方案设计思路及主要问题｜2019DDI, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4dcc182186f2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1514298, encodeId=64db151429874, content=<a href='/topic/show?id=9d7c80e14b3' target=_blank style='color:#2F92EE;'>#联合用药#</a>, objectTitle=赵水平建议我国调脂原则：极高危患者强化降脂，中危患者中等强度降脂，必要时联合用药, objectType=article, longId=181595, objectId=6289181595a5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6289181595a5, replyNumber=0, likeNumber=64, createdTime=2019-10-21, rootId=0, userName=ms4964546379600229, userId=36f510649899, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6289181595a5, moduleTitle=赵水平建议我国调脂原则：极高危患者强化降脂，中危患者中等强度降脂，必要时联合用药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6289181595a5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1514297, encodeId=4575151429e47, content=<a href='/topic/show?id=9d7c80e14b3' target=_blank style='color:#2F92EE;'>#联合用药#</a>, objectTitle=2019 专家建议：舌下免疫治疗联合用药及潜在不良反应的管理, objectType=article, longId=177879, objectId=528a1e78797d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=528a1e78797d, replyNumber=0, likeNumber=52, createdTime=2019-08-19, rootId=0, userName=ms4964546379600229, userId=36f510649899, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=528a1e78797d, moduleTitle=2019 专家建议：舌下免疫治疗联合用药及潜在不良反应的管理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=528a1e78797d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1514296, encodeId=596c1514296f3, content=<a href='/topic/show?id=9d7c80e14b3' target=_blank style='color:#2F92EE;'>#联合用药#</a>, objectTitle=Microbiologyopen：联合用药或能击败“超级真菌”, objectType=article, longId=172242, objectId=47a31e22427f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=47a31e22427f, replyNumber=0, likeNumber=72, createdTime=2019-06-28, rootId=0, userName=ms4964546379600229, userId=36f510649899, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=47a31e22427f, moduleTitle=Microbiologyopen：联合用药或能击败“超级真菌”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=47a31e22427f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1514295, encodeId=b76c1514295ea, content=<a href='/topic/show?id=9d7c80e14b3' target=_blank style='color:#2F92EE;'>#联合用药#</a>, objectTitle=Brentuximab vedotin联合用药有效改善复发/难治霍奇金淋巴瘤预后, objectType=article, longId=168147, objectId=52db16814e29, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=52db16814e29, replyNumber=0, likeNumber=102, createdTime=2019-06-13, rootId=0, userName=ms4964546379600229, userId=36f510649899, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=52db16814e29, moduleTitle=Brentuximab vedotin联合用药有效改善复发/难治霍奇金淋巴瘤预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=52db16814e29)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1514294, encodeId=eac9151429407, content=<a href='/topic/show?id=9d7c80e14b3' target=_blank style='color:#2F92EE;'>#联合用药#</a>, objectTitle=炉甘石洗剂的8种联合用药方案, objectType=article, longId=163276, objectId=51b81632e604, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=51b81632e604, replyNumber=0, likeNumber=82, createdTime=2019-03-31, rootId=0, userName=ms4964546379600229, userId=36f510649899, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=51b81632e604, moduleTitle=炉甘石洗剂的8种联合用药方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=51b81632e604)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1514293, encodeId=564e151429386, content=<a href='/topic/show?id=9d7c80e14b3' target=_blank style='color:#2F92EE;'>#联合用药#</a>, objectTitle=Neuro-Oncology：科学家开发出小儿脑瘤新疗法联合用药可减缓肿瘤生长并克服耐药性, objectType=article, longId=163041, objectId=d36f1630413f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d36f1630413f, replyNumber=0, likeNumber=95, createdTime=2019-03-28, rootId=0, userName=ms4964546379600229, userId=36f510649899, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d36f1630413f, moduleTitle=Neuro-Oncology：科学家开发出小儿脑瘤新疗法联合用药可减缓肿瘤生长并克服耐药性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d36f1630413f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1514292, encodeId=d7211514292c0, content=<a href='/topic/show?id=9d7c80e14b3' target=_blank style='color:#2F92EE;'>#联合用药#</a>, objectTitle=Sci Transl Med:KRAS突变型肺癌或喜迎MEK抑制剂联合用药, objectType=article, longId=162939, objectId=156a1629396a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=156a1629396a, replyNumber=0, likeNumber=75, createdTime=2019-03-26, rootId=0, userName=ms4964546379600229, userId=36f510649899, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=156a1629396a, moduleTitle=Sci Transl Med:KRAS突变型肺癌或喜迎MEK抑制剂联合用药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=156a1629396a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1514291, encodeId=7fa3151429157, content=<a href='/topic/show?id=9d7c80e14b3' target=_blank style='color:#2F92EE;'>#联合用药#</a>, objectTitle=Arthritis Rheumatol：依那西普和甲氨蝶呤单药或联合用药治疗银屑病关节炎的疗效, objectType=article, longId=160634, objectId=856e1606342d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=856e1606342d, replyNumber=0, likeNumber=122, createdTime=2019-02-22, rootId=0, userName=ms4964546379600229, userId=36f510649899, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=856e1606342d, moduleTitle=Arthritis Rheumatol：依那西普和甲氨蝶呤单药或联合用药治疗银屑病关节炎的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=856e1606342d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1514290, encodeId=4c9f151429048, content=<a href='/topic/show?id=9d7c80e14b3' target=_blank style='color:#2F92EE;'>#联合用药#</a>, objectTitle=六类降压药的作用特点、临床选择、用药交待、联合用药，全在这里！, objectType=article, longId=160544, objectId=35b2160544fb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=35b2160544fb, replyNumber=0, likeNumber=68, createdTime=2019-02-21, rootId=0, userName=ms4964546379600229, userId=36f510649899, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=35b2160544fb, moduleTitle=六类降压药的作用特点、临床选择、用药交待、联合用药，全在这里！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=35b2160544fb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1514289, encodeId=ee87151428978, content=<a href='/topic/show?id=9d7c80e14b3' target=_blank style='color:#2F92EE;'>#联合用药#</a>, objectTitle=联合用药治疗HIV和利什曼病共感染, objectType=article, longId=159086, objectId=a6391590864b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a6391590864b, replyNumber=0, likeNumber=91, createdTime=2019-01-29, rootId=0, userName=ms4964546379600229, userId=36f510649899, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a6391590864b, moduleTitle=联合用药治疗HIV和利什曼病共感染, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a6391590864b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1514288, encodeId=4ce315142884e, content=<a href='/topic/show?id=9d7c80e14b3' target=_blank style='color:#2F92EE;'>#联合用药#</a>, objectTitle=Semin Arthritis Rheu：类风湿性关节炎中托法替尼单药或联合用药的安全性比较, objectType=article, longId=145040, objectId=860714504022, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=860714504022, replyNumber=0, likeNumber=81, createdTime=2018-07-25, rootId=0, userName=ms4964546379600229, userId=36f510649899, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=860714504022, moduleTitle=Semin Arthritis Rheu：类风湿性关节炎中托法替尼单药或联合用药的安全性比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=860714504022)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1514287, encodeId=49f7151428ed9, content=<a href='/topic/show?id=9d7c80e14b3' target=_blank style='color:#2F92EE;'>#联合用药#</a>, objectTitle=人工智能系统可助预测联合用药副作用, objectType=article, longId=144264, objectId=858a14426495, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=858a14426495, replyNumber=0, likeNumber=109, createdTime=2018-07-14, rootId=0, userName=ms4964546379600229, userId=36f510649899, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=858a14426495, moduleTitle=人工智能系统可助预测联合用药副作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=858a14426495)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1514286, encodeId=6998151428660, content=<a href='/topic/show?id=9d7c80e14b3' target=_blank style='color:#2F92EE;'>#联合用药#</a>, objectTitle=骨质疏松的五种联合用药, objectType=article, longId=141970, objectId=ddb71419e022, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ddb71419e022, replyNumber=0, likeNumber=0, createdTime=2018-07-01, rootId=0, userName=ms4964546379600229, userId=36f510649899, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ddb71419e022, moduleTitle=骨质疏松的五种联合用药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ddb71419e022)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1514285, encodeId=e2b91514285ba, content=<a href='/topic/show?id=9d7c80e14b3' target=_blank style='color:#2F92EE;'>#联合用药#</a>, objectTitle=骨质疏松的5种联合用药, objectType=article, longId=137616, objectId=b5a913e6163e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b5a913e6163e, replyNumber=0, likeNumber=82, createdTime=2018-05-10, rootId=0, userName=ms4964546379600229, userId=36f510649899, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b5a913e6163e, moduleTitle=骨质疏松的5种联合用药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b5a913e6163e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1514284, encodeId=514b151428479, content=<a href='/topic/show?id=9d7c80e14b3' target=_blank style='color:#2F92EE;'>#联合用药#</a>, objectTitle=硝苯地平缓释片Ⅰ、Ⅱ和Ⅲ有怎么区别？你别吃错了！（附联合用药方案）, objectType=article, longId=136830, objectId=e46b13683045, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e46b13683045, replyNumber=0, likeNumber=75, createdTime=2018-05-01, rootId=0, userName=ms4964546379600229, userId=36f510649899, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e46b13683045, moduleTitle=硝苯地平缓释片Ⅰ、Ⅱ和Ⅲ有怎么区别？你别吃错了！（附联合用药方案）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e46b13683045)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1514283, encodeId=c93b1514283d5, content=<a href='/topic/show?id=9d7c80e14b3' target=_blank style='color:#2F92EE;'>#联合用药#</a>, objectTitle=硝苯地平缓释片Ⅰ、Ⅱ和Ⅲ有怎么区别？别吃错了！（附联合用药方案）, objectType=article, longId=136623, objectId=53a3136623b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=53a3136623b0, replyNumber=0, likeNumber=76, createdTime=2018-04-28, rootId=0, userName=ms4964546379600229, userId=36f510649899, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=53a3136623b0, moduleTitle=硝苯地平缓释片Ⅰ、Ⅱ和Ⅲ有怎么区别？别吃错了！（附联合用药方案）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=53a3136623b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1514282, encodeId=e68c151428242, content=<a href='/topic/show?id=9d7c80e14b3' target=_blank style='color:#2F92EE;'>#联合用药#</a>, objectTitle=欧洲食品药品监督管理局启动默沙东的Keytruda/chemo联合用药的审查, objectType=article, longId=136410, objectId=261d13641072, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=261d13641072, replyNumber=0, likeNumber=98, createdTime=2018-04-26, rootId=0, userName=ms4964546379600229, userId=36f510649899, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=261d13641072, moduleTitle=欧洲食品药品监督管理局启动默沙东的Keytruda/chemo联合用药的审查, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=261d13641072)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1514281, encodeId=a265151428163, content=<a href='/topic/show?id=9d7c80e14b3' target=_blank style='color:#2F92EE;'>#联合用药#</a>, objectTitle=Cell：联合用药让肿瘤免疫治疗“如虎添翼”, objectType=article, longId=122244, objectId=b0b212224489, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b0b212224489, replyNumber=0, likeNumber=71, createdTime=2017-12-06, rootId=0, userName=ms4964546379600229, userId=36f510649899, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b0b212224489, moduleTitle=Cell：联合用药让肿瘤免疫治疗“如虎添翼”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b0b212224489)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1514280, encodeId=f4e7151428087, content=<a href='/topic/show?id=9d7c80e14b3' target=_blank style='color:#2F92EE;'>#联合用药#</a>, objectTitle=Nat Commun：科学新发现：肿瘤细胞可以逃脱抗癌药物的追捕，联合用药效果更好, objectType=article, longId=118197, objectId=8a8011819edc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8a8011819edc, replyNumber=0, likeNumber=103, createdTime=2017-11-01, rootId=0, userName=ms4964546379600229, userId=36f510649899, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8a8011819edc, moduleTitle=Nat Commun：科学新发现：肿瘤细胞可以逃脱抗癌药物的追捕，联合用药效果更好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8a8011819edc)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

联合用药

2020-05-29

ms4964546379600229 (审核中...)

前往app查看评论内容

#联合用药#

抗肿瘤药联合用药的早期临床方案设计思路及主要问题｜2019DDI

2019-11-01

ms4964546379600229 (审核中...)

前往app查看评论内容

#联合用药#

赵水平建议我国调脂原则：极高危患者强化降脂，中危患者中等强度降脂，必要时联合用药

2019-10-21

ms4964546379600229 (审核中...)

前往app查看评论内容

#联合用药#

2019 专家建议：舌下免疫治疗联合用药及潜在不良反应的管理

2019-08-19

ms4964546379600229 (审核中...)

前往app查看评论内容

#联合用药#

Microbiologyopen：联合用药或能击败“超级真菌”

2019-06-28

ms4964546379600229 (审核中...)

前往app查看评论内容

#联合用药#

Brentuximab vedotin联合用药有效改善复发/难治霍奇金淋巴瘤预后

2019-06-13

ms4964546379600229 (审核中...)

前往app查看评论内容

#联合用药#

炉甘石洗剂的8种联合用药方案

2019-03-31

ms4964546379600229 (审核中...)

前往app查看评论内容

#联合用药#

Neuro-Oncology：科学家开发出小儿脑瘤新疗法联合用药可减缓肿瘤生长并克服耐药性

2019-03-28

ms4964546379600229 (审核中...)

前往app查看评论内容

#联合用药#

Sci Transl Med:KRAS突变型肺癌或喜迎MEK抑制剂联合用药

2019-03-26

ms4964546379600229 (审核中...)

前往app查看评论内容

#联合用药#

Arthritis Rheumatol：依那西普和甲氨蝶呤单药或联合用药治疗银屑病关节炎的疗效

2019-02-22

ms4964546379600229 (审核中...)

前往app查看评论内容

#联合用药#

六类降压药的作用特点、临床选择、用药交待、联合用药，全在这里！

2019-02-21

ms4964546379600229 (审核中...)

前往app查看评论内容

#联合用药#

联合用药治疗HIV和利什曼病共感染

2019-01-29

ms4964546379600229 (审核中...)

前往app查看评论内容

#联合用药#

Semin Arthritis Rheu：类风湿性关节炎中托法替尼单药或联合用药的安全性比较

2018-07-25

ms4964546379600229 (审核中...)

前往app查看评论内容

#联合用药#

人工智能系统可助预测联合用药副作用

2018-07-14

ms4964546379600229 (审核中...)

前往app查看评论内容

#联合用药#

骨质疏松的五种联合用药

2018-07-01

ms4964546379600229 (审核中...)

前往app查看评论内容

#联合用药#

骨质疏松的5种联合用药

2018-05-10

ms4964546379600229 (审核中...)

前往app查看评论内容

#联合用药#

硝苯地平缓释片Ⅰ、Ⅱ和Ⅲ有怎么区别？你别吃错了！（附联合用药方案）

2018-05-01

ms4964546379600229 (审核中...)

前往app查看评论内容

#联合用药#

硝苯地平缓释片Ⅰ、Ⅱ和Ⅲ有怎么区别？别吃错了！（附联合用药方案）

2018-04-28

ms4964546379600229 (审核中...)

前往app查看评论内容

#联合用药#

欧洲食品药品监督管理局启动默沙东的Keytruda/chemo联合用药的审查

2018-04-26

ms4964546379600229 (审核中...)

前往app查看评论内容

#联合用药#

Cell：联合用药让肿瘤免疫治疗“如虎添翼”

2017-12-06

ms4964546379600229 (审核中...)

前往app查看评论内容

#联合用药#

Nat Commun：科学新发现：肿瘤细胞可以逃脱抗癌药物的追捕，联合用药效果更好

2017-11-01

科室
- - 订阅+
  - 更多科室
工具
服务